Cross-presentation of tumor antigens by bone marrow derived antigen-presenting cells (APCs) is the dominant mechanism in tolerance induction to B-cell lymphomas.

被引：0
|
作者：
Sotomayor, EM
Borrello, I
Rattis, FM
Abrams, J
Levitsky, HI
机构：
[1] H Lee Moffit Canc Ctr & Res Inst, Tampa, FL USA
[2] Johns Hopkins Oncol Ctr, Baltimore, MD USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2795
引用
收藏
页码：629A / 629A
页数：1
相关论文
共 48 条
  • [31] INDUCTION OF IGA B-CELL DIFFERENTIATION OF BONE-MARROW-DERIVED B-CELLS BY PEYERS PATCH AUTOREACTIVE HELPER T-CELLS
    KIHIRA, T
    KAWANISHI, H
    IMMUNOLOGICAL INVESTIGATIONS, 1995, 24 (05) : 701 - 711
  • [32] Induction of CD4+CD25+ Treg by tolerance-inducing antigen-presenting cells derived from bone marrow cultures initiated with anti-CD200R2/3.
    Gorczynski, RM
    Lee, L
    Boudakov, I
    CLINICAL IMMUNOLOGY, 2005, 115 : S10 - S11
  • [33] Antitumor cytotoxicity induced by bone-marrow-derived antigen-presenting cells is facilitated by the tumor suppressor protein p53 via regulation of IL-12
    Slatter, Tania L.
    Wilson, Michelle
    Tang, Chingwen
    Campbell, Hamish G.
    Ward, Vernon K.
    Young, Vivienne L.
    Van Ly, David
    Fleming, Nicholas I.
    Braithwaite, Antony W.
    Baird, Margaret A.
    ONCOIMMUNOLOGY, 2016, 5 (03):
  • [34] CD8 T-cell priming upon mRNA vaccination is restricted to bone-marrow-derived antigen-presenting cells and may involve antigen transfer from myocytes
    Lazzaro, Sandra
    Giovani, Cinzia
    Mangiavacchi, Simona
    Magini, Diletta
    Maione, Domenico
    Baudner, Barbara
    Geall, Andrew J.
    De Gregorio, Ennio
    D'Oro, Ugo
    Buonsanti, Cecilia
    IMMUNOLOGY, 2015, 146 (02) : 312 - 326
  • [35] Inhibition of JAK-STAT3 signaling in B-cell lymphomas enhances antigen presentation and restore responsiveness of T cells from tumor bearing hosts: Implications for immunotherapy of B-cell malignancies.
    Cheng, FD
    Cuenca, AG
    Wang, HW
    Huang, M
    Shain, KH
    Jove, R
    Yu, H
    Sotomayor, EM
    BLOOD, 2001, 98 (11) : 613A - 613A
  • [36] Extracellular vesicles derived from antigen-presenting cells pulsed with foot and mouth virus vaccine-antigens act as carriers of viral proteins and stimulate B cell response
    Menay, Florencia
    Cocozza, Federico
    Gravisaco, Maria J.
    Elisei, Analia
    Re, Javier Ignacio
    Ferella, Alejandra
    Waldner, Claudia
    Mongini, Claudia
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [37] Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: Dominant role of cross-tolerance to tumor antigens
    Cuenca, A
    Cheng, FD
    Wang, HW
    Brayer, J
    Horna, P
    Gu, LP
    Bien, H
    Borrello, IM
    Levitsky, HI
    Sotomayor, EM
    CANCER RESEARCH, 2003, 63 (24) : 9007 - 9015
  • [38] Cognate interactions between memory T cells and tumor antigen-presenting dendritic cells from bone marrow of breast cancer patients:: Bidirectional cell stimulation, survival and antitumor activity in vivo
    Bai, LH
    Beckhove, P
    Feuerer, M
    Umansky, V
    Choi, C
    Solomayer, FSEF
    Diel, IJ
    Schirrmacher, V
    INTERNATIONAL JOURNAL OF CANCER, 2003, 103 (01) : 73 - 83
  • [39] Cucurbitacins, a family of natural compounds that effectively disrupt Stat3 signaling in antigen-presenting cells (APCs) are promising agents to overcome tumor-induced CD4+T-cell tolerance.
    Cheng, FD
    Wang, HW
    Suarez, A
    Horna, P
    Sebti, S
    Sotomayor, EM
    BLOOD, 2005, 106 (11) : 428A - 428A
  • [40] EVIDENCE FOR EFFECTS OF INTERLEUKIN-4 (B-CELL STIMULATORY FACTOR-I) ON MACROPHAGES - ENHANCEMENT OF ANTIGEN PRESENTING ABILITY OF BONE MARROW-DERIVED MACROPHAGES
    ZLOTNIK, A
    FISCHER, M
    ROEHM, N
    ZIPORI, D
    JOURNAL OF IMMUNOLOGY, 1987, 138 (12): : 4275 - 4279
12345